Anzeige
Mehr »
Sonntag, 01.03.2026 - Börsentäglich über 12.000 News
Wegweisende News: NurExone - Pionier der regenerativen neuronalen Medizin!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Stockhead

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
16.02.Health Food Symmetry leads way in new gut-boosting fibre classification
16.02.Closing Bell: ASX limps into the week with a modest win as tech rebounds
16.02.Resources Top 5: Genesis drawn to Magnetic in Laverton gold shake-up
16.02.How to master the frequent flyer game of reward flights
16.02.Lunch Wrap: ASX trickles into green as tech leads bounce and earnings surprise
16.02.Break it Down: Genesis moves on Magnetic in Laverton gold consolidation play
16.02.Code red: AI unleashes its own tech wreck
15.02.Ten Bagger: Dazzled by critical minerals? John Forwood's been loading up on copper
15.02.Kristie Batten: ETM building multiple options in critical minerals
15.02.Harvest Tech quietly goes mission-critical offshore
14.02.The 'great wealth migration' will reshape global markets
13.02.Gold Digger: As gold's bull run wobbles, fundies still say miners are undervalued
13.02.Resources Top 5: Goldies hold their nerve in a spooked Friday market
13.02.Closing Bell: Tech brutalised as the ASX scrambles for safety on Friday the 13th
13.02.How to become a property investor for $300,000
13.02.Scott Power: ASX health stocks under fire in 'brutal' reporting week
13.02.ASX Small Caps Weekly Form Guide
13.02.Lunch Wrap: ASX cops a whack as tech rolls over; Cochlear plunges 17pc
13.02.Break it Down: Hot Chili pockets $40m to accelerate drilling at La Verde
13.02.Break it Down: Entropy secures patent protection until 2042 for IV-infused psilocin
13.02.Private markets offer refuge as the traditional 60/40 portfolio crumbles
12.02.The race to supply American tungsten is on as China-US tensions mount
12.02.Dr Boreham's Crucible: A rival may be circling, but ResMed isn't losing any sleep
12.02.ASX healthcare players focusing on rare diseases as incentives stack up
12.02.How AI is rewiring hearing tech, and here's where ASX-listed Audeara fits